Clinical Trial Update: Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study

View source ↗

Summary

A real-world retrospective study evaluating long-acting cabotegravir and rilpivirine in people living with HIV-1 infection, including subtype A6; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)
• rilpivirine (rilpivirine)

Snippet

Sponsor: Pomeranian Medical University Szczecin | Conditions: Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection | Status: NOT_YET_RECRUITING